Journal: Journal of applied physiology (Bethesda, Md. : 1985)
Article Title: Influence of training intensity on adaptations in acid/base transport proteins, muscle buffer capacity, and repeated-sprint ability in active men.
doi: 10.1152/japplphysiol.00630.2016
Figure Lengend Snippet: Fig. 3. Basigin antibody validation. Using Western blotting, two duplicate gels (1 and 2) were loaded with four lanes of a single sample of skeletal muscle homogenate (M), six differ- ent concentrations of an internal standard (IS1– IS6: 8–38 g protein), and one lane of a Hep G2 cell lysate positive control (ve). Follow- ing transfer, membrane 1A was immunoblotted with a mouse monoclonal anti-basigin antibody (sc-21746), and membrane 2A was immuno- blotted with a different mouse monoclonal anti- basigin antibody (sc-46700). After imaging, the peroxidase of the horseradish peroxidase- conjugated secondary antibodies was inacti- vated by 15 min of H2O2 incubation. Both membranes were reprobed (1B and 2B) with a goat polyclonal anti-basigin antibody (sc- 9757). See text for additional details on immu- noblotting.
Article Snippet: Primary Rabbit polyclonal anti-MCT1 Merck Millipore AB3540P/2136555 1:1,000 1:15,000 Rabbit polyclonal anti-MCT4 Merck Millipore AB3316P/2397059 1:1,000 1:20,000 Mouse monoclonal anti-basigin Santa Cruz sc-21746/K1913 1:200 1:7,500 Mouse monoclonal anti-NHE1 Merck Millipore MAB3140/2283852 1:500 1:7,500 Rabbit polyclonal anti-NBCe1 Cell Signaling 11867/0001 1:500 1:5,000 Rabbit polyclonal anti-CAII Santa Cruz sc-25596/F0611 1:1,250 1:30,000 Mouse monoclonal anti-CAIII Abnova H00000761-M02/12243-S1 1:2,500 1:40,000 Mouse polyclonal anti-CAIV Abnova H00000762-B02P/08325 WULz 1:500 1:10,000 Mouse polyclonal anti-CAXIV Abnova H00023632-B01P/08358 WULz 1:750 1:10,000 Secondary Goat anti-mouse IgG Perkin Elmer NEF822001EA Goat anti-rabbit IgG Perkin Elmer NEF812001EA J Appl Physiol • doi:10.1152/japplphysiol.00630.2016 • www.jappl.org Overall basigin abundance changed in response to training (time main effect: F3,37.2 4.47, P 0.009) (Fig. 4C).
Techniques: Biomarker Discovery, Western Blot, Positive Control, Membrane, Imaging, Incubation